During episode #92 of The Weekly Bioanalysis , our hosts, John and Dom, dive into GLP-1 receptor agonistsoriginally developed for type 2 diabetesand how their mechanisms (stimulating insulin, slowing gastric emptying, and reducing glucagon) also drive significant weight-loss effects
Resilience by having multiple suppliers is not incentivised Generic manufacturers must follow regulations of the country where their medicines are sold
On the other hand, Wegovy is specifically approved for weight loss and contains a higher dose of semaglutide, making it more effective for shedding pounds
To correct for the partial-volume effect, fractions of CSF and brain tissue (gray and white matters) were determined within the voxel using FSL FAST segmentation
A&B Booster B12, Vitamin C Get your energy boost